Explore an IVF clinical trial option designed with care. Now screening in Clovis, CA for the Fertilo (FIRST) Study — a Phase 3 clinical trial evaluating a potentially gentler approach to assisted reproductive technology.
Am I Eligible?Enrollment includes women 18–35 years old.
PGT is not allowed during participation.
Estimated enrollment across sites.
This clinical study is researching a new fertility option that may shorten the in vitro fertilization (IVF) process by maturing oocytes (eggs) in the lab instead of the body.
This may reduce the risk of Ovarian Hyperstimulation Syndrome (OHSS) and shorten the overall treatment process. The study is evaluating an investigational biologic, Fertilo, for in vitro maturation (IVM). If you're having trouble getting pregnant or planning to use assisted reproductive technology, you may be eligible to participate.
I'M INTERESTED
This clinical research study is evaluating an investigational treatment designed to improve the outcome of in vitro maturation (IVM), and potentially reduce the number of hormone injections compared with typical IVF stimulation strategies.
The study compares Fertilo to a standard IVM system and evaluates outcomes including ongoing pregnancy at 12 weeks gestation. Participation is voluntary, and not everyone will qualify. All study-related items are reviewed during informed consent.
Women's Specialty & Fertility Center
729 North Medical Center Drive W, #205, Clovis, CA 93611
Phone: (559) 299-7700
We confirm basic eligibility, review the study details, and complete informed consent if appropriate.
Your eggs are matured using either Fertilo or the standard IVM comparator, per your study assignment.
Embryos are grown to the blastocyst stage, cryopreserved, and later transferred according to protocol timelines.
Fill out the form below to determine if you may be eligible for the research study. If you meet the initial criteria, a research coordinator from our team will be in contact.